We are live on ! Find out more
INVA icon

Innoviva

236 hedge funds and large institutions have $1.49B invested in Innoviva in 2022 Q1 according to their latest regulatory filings, with 41 funds opening new positions, 91 increasing their positions, 73 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

177% more call options, than puts

Call options by funds: $2.57M | Put options by funds: $926K

95% more first-time investments, than exits

New positions opened: 41 | Existing positions closed: 21

25% more repeat investments, than reductions

Existing positions increased: 91 | Existing positions reduced: 73

21% more capital invested

Capital invested by funds: $1.23B → $1.49B (+$261M)

8% more funds holding

Funds holding: 218236 (+18)

8.17% more ownership

Funds ownership: 102.25%110.42% (+8.2%)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

Holders
236
Holders Change
+18
Holders Change %
+8.26%
% of All Funds
3.71%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
41
Increased
91
Reduced
73
Closed
21
Calls
$2.57M
Puts
$926K
Net Calls
+$1.64M
Net Calls Change
-$290K

INVA Hedge Fund Activity: Q1 2022 in Review

236 of the 6,360 institutional investors tracked by Wall St. Rank reported a position in Innoviva (INVA) for Q1 2022, worth a combined $1.49B — up 21% from $1.23B a quarter earlier.

Buyers outnumbered sellers: 41 funds opened new INVA positions and 21 closed out — a net gain of 20 holders — while 91 added to existing stakes and 73 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $19.2M. The largest seller was Skandinaviska Enskilda Banken (SEB), exiting entirely with an estimated $19.9M sold.

  • 236 institutional investors held Innoviva (INVA) as of Q1 2022, up from 218 in Q4 2021.
  • Funds reported $1.49B of Innoviva stock for Q1 2022, up 21% quarter-over-quarter.
  • 41 funds opened new Innoviva positions in Q1 2022 and 21 closed out, a net change of +20 holders.
  • The largest Innoviva buyer in Q1 2022 was Morgan Stanley, an estimated $19.2M added.
  • The largest Innoviva seller in Q1 2022 was Skandinaviska Enskilda Banken (SEB), an estimated $19.9M sold.

Based on aggregated 13F filings for Q1 2022.